Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2016-05-25

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.14m09681PMID 27249080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study.

  2013cited by this paper
• Outcomes of Prolonged Exposure therapy for veterans with posttraumatic stress disorder.

  2013cited by this paper
• A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

  2013cited by this paper
• Are We Winning the War Against Posttraumatic Stress Disorder?

  2012cited by this paper
• The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats

  2012cited by this paper
• Noradrenergic α1 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial

  2012cited by this paper
• Post-traumatic stress disorder and medication adherence: results from the Mind Your Heart study.

  2012cited by this paper
• For veterans with mild traumatic brain injury, improved posttraumatic stress disorder severity and sleep correlated with symptomatic improvement.

  2012cited by this paper
• Catecholamine influences on dorsolateral prefrontal cortical networks.

  2011cited by this paper
• Doxazosin treatment for posttraumatic stress disorder.

  2010cited by this paper
• Medication Adherence and Its Effect on Relapse Among Patients Discharged from a Veterans Affairs Posttraumatic Stress Disorder Treatment Program

  2009cited by this paper
• Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder.

  2008cited by this paper
• Change in posttraumatic stress disorder symptoms: do clinicians and patients agree?

  2008cited by this paper
• Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

  2007cited by this paper
• A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.

  2007cited by this paper
• Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities.

  2007cited by this paper
• Cognitive processing therapy for veterans with military-related posttraumatic stress disorder.

  2006cited by this paper
• Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

  2003cited by this paper
• Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.

  2003cited by this paper
• Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.

  2002cited by this paper
• Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons.

  2002cited by this paper
• Double-Blind Placebo-Controlled Pilot Study of Sertraline in Military Veterans With Posttraumatic Stress Disorder

  2002cited by this paper
• Prevalence of sexual dysfunction among newer antidepressants.

  2002cited by this paper
• Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

  2001cited by this paper
• Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.

  2000cited by this paper
• A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex.

  1999cited by this paper
• Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.

  1996cited by this paper
• The development of a Clinician-Administered PTSD Scale

  1995cited by this paper
• Fluoxetine in posttraumatic stress disorder.

  1994cited by this paper
• Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.

  1991cited by this paper
• The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

  1989cited by this paper
• New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.

  1988cited by this paper
• The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

  1986cited by this paper
• A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

  1982cited by this paper

• Doxazosin zur Behandlung posttraumatischer Albträume ergänzend zu traumafokussierter kognitiver Verhaltenstherapie

  2026cites this paper
• Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)

  2025cites this paper
• Evidence-Based Prescribing of Prazosin in Post-Traumatic Stress Disorder

  2025cites this paper
• Doxazosin for the Treatment of Nightmares in Post-Traumatic Stress Disorder: A Scoping Review of Clinical Evidence

  2025cites this paper
• Doxazosin for the treatment of mental health disorders: A scoping review

  2025influential citation
• Repurposing Existing Drugs for the Treatment of Post-Traumatic Stress Disorder

  2025cites this paper
• Evidence for locus coeruleus-norepinephrine system abnormality in military PTSD revealed by neuromelanin-sensitive MRI.

  2024cites this paper
• Doxazosin Immediate Release as a Novel Treatment for Nightmares in Posttraumatic Stress Disorder

  2024cites this paper
• Emerging pharmacological agents for post-traumatic stress disorder show promise, but more evidence is needed

  2024cites this paper
• Pharmakologische Behandlung der Posttraumatischen Belastungsstörung

  2024cites this paper
• A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder

  2024cites this paper
• Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression

  2022cites this paper
• The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials

  2022influential citation
• An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update.

  2022cites this paper
• Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents.

  2022cites this paper
• Efficacy and acceptability of psychotherapeutic and pharmacological interventions for trauma-related nightmares: A systematic review and network meta-analysis.

  2022cites this paper
• Sleep disturbances in traumatic exposure and post-traumatic stress disorder

  2021cites this paper
• Sleep management in posttraumatic stress disorder: a systematic review and meta-analysis.

  2021cites this paper
• Key Clinical Interest Outcomes of Pharmaceutical Administration for Veterans With Post-Traumatic Stress Disorder Based on Pooled Evidences of 36 Randomised Controlled Trials With 2,331 Adults

  2020cites this paper
• Neuroendocrinology Letters-Neuro Endocrinol Lett

  2020cites this paper
• Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia

  2020cites this paper
• Doxazosin for the treatment of nightmare disorder: A diary-based case study

  2020cites this paper
• Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.

  2020cites this paper
• P.068 Stress-protective effects of a novel peptide GABAergic system modulator in animal models of anxiety, depression and post-traumatic stress disorder

  2020cites this paper
• Treating nightmares in PTSD with doxazosin: a report of three cases

  2019cites this paper
• Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.

  2019cites this paper
• Theranostic pharmacology in PTSD: Neurobiology and timing

  2019cites this paper
• Pharmacology of Sleep and PTSD: Prazosin - An Alpha-1 Adrenoreceptor Antagonist Approach to Post-traumatic Stress Disorder Pharmacotherapy

  2018cites this paper
• The Walking Wounded: Emerging Treatments for PTSD

  2018cites this paper
• Pharmacotherapy for Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder

  2018cites this paper
• Evidenced-Based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches

  2018cites this paper
• Medication for Sleep Problems in Posttraumatic Stress Disorder

  2018cites this paper
• Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans.

  2018cites this paper
• An Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future Research on Doxazosin.

  2018cites this paper
• Hospitalization Risk With Benzodiazepine and Opioid Use in Veterans With Posttraumatic Stress Disorder.

  2017cites this paper
• Prazosin and Doxazosin for PTSD Are Underutilized and Underdosed

  2017cites this paper
• Sleep in PTSD: Conceptual model and novel directions in brain-based research and interventions.

  2017cites this paper
• Evidence for Using Doxazosin in the Treatment of Posttraumatic Stress Disorder.

  2016cites this paper